Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AG-270 |
Trade Name | |
Synonyms | AG270|AG 270 |
Drug Descriptions |
AG-270 inhibits methionine adenosyltransferase II alpha (MAT2A), to induce cell death of tumor cells reliant on S-Adenosyl-L-methionine (SAM) synthesis (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 13299-99-5 |
NCIT ID | C153180 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AG-270 | AG-270 | 0 | 1 |
AG-270 + Docetaxel | AG-270 Docetaxel | 0 | 1 |
AG-270 + Gemcitabine + Nab-paclitaxel | AG-270 Gemcitabine Nab-paclitaxel | 0 | 1 |